Skip to content

Towards Pandemic Equity: Lessons from 30 Years of Syndemic Activism

  • Dorrit Walsh

By Mike Frick and Mark Harrington The articles in this 30th anniversary issue of TAGline grapple with “pandemic equity,” an increasingly common catchphrase in global health. COVID-19 has shown that “equity,” like its cousins “justice,” “fairness,” and “equality,” is one…

Read more

The LAT CAB Responds to MedinCell and Medicines Patent Pool License on a New Long-Acting Malaria Formulation

  • Dorrit Walsh
As the global Long-Acting Technologies Community Advisory Board (LAT CAB) representing vast civil society networks, and people living with and affected by malaria, HIV, tuberculosis, and the hepatitis C virus (HCV) across the world, we welcome the efforts leading to the development of an investigational long-acting injectable (LAI) formulation of ivermectin to fight malaria transmission,  mdc-STM currently in preclinical stage, and developed by MedinCell.
Read more

Treatment Action Group Statement on Retirement of Dr. Anthony S. Fauci

  • Dorrit Walsh
Treatment Action Group (TAG) meets with sadness the announcement by Dr. Anthony S. Fauci of his retirement as Director of the National Institute of Allergy and Infectious Diseases (NIAID), Chief of the NIAID Laboratory of Immunoregulation, and Chief Medical Advisor to President Biden, effective in December 2022.
Read more

LAT CAB Video Presentation

  • Dorrit Walsh
This video, offered here in English, French, and Spanish, was made to be shown at the AfroCAB booth at the 24th International AIDS Conference.
Read more
Cover of Pipeline Report 2022. Black cover with grey type and decorative bright green lines

2022 Pipeline Report

  • Dorrit Walsh
Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
Read more

Research in Action Awards 2022

  • Dorrit Walsh
Save the date for Tuesday, November 16, 2021! TAG’s 2021 Research in Action Awards will honor some of the best and brightest activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C across the U.S. and around the world. This year we’ll once again gather virtually to ensure this year’s event is safe and open for participation to our allies and friends across the U.S. and world.
Read more

Treatment Action Group Statement on NYC DOHMH Monkeypox Vaccination Announcement

  • Dorrit Walsh
In response to this morning's announcement by the New York City Department of Health and Mental Hygiene (NYC DOHMH) that the DOHMH would open a temporary monkeypox vaccination clinic at the Chelsea Sexual Health Clinic in New York, Treatment Action Group's Executive Director, Mark Harrington, and TAG HIV Project Director Riko A. Boone, MSW, MPH, MA, said:
Read more
Cover of TAG's annual report. Reads: 2021 TAG Annual Report, Progress in the Fight for better treatment, prevention, a vaccine, and a cure for HIV, Tuberculosis, and Hepatitis C Virus

2021 Annual Report

  • Dorrit Walsh
This year we celebrate the unending dedication and accomplishments of TAG’s staff. They persevered through the challenges of an ongoing pandemic in 2021 to find new ways to carry out our work.
Read more
Back To Top